Latanoprost

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2372 publications

Changes in Corneal Epithelial Barrier Function and Zonula Occludens-1 Distribution with Concomitant Use of Silver Nitrate and Latanoprost in Rabbits.

Changes in Corneal Epithelial Barrier Function and Zonula Occludens-1 Distribution with Concomitant Use of Silver Nitrate and Latanoprost in Rabbits.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

Published: July 15, 2026

Omidenepag isopropyl (Omlonti) for glaucoma.

Omidenepag isopropyl (Omlonti) for glaucoma.

Journal: The Medical letter on drugs and therapeutics

Published: July 14, 2026

Black Elderberry Exposure in Apparent Idiopathic Mild Acute Pancreatitis: A Case Report.

Black Elderberry Exposure in Apparent Idiopathic Mild Acute Pancreatitis: A Case Report.

Journal: Cureus

Published: July 10, 2026

Exploratory Analysis of Glaucoma-Associated SNPs in a Colombian Cohort Highlights Potential Involvement of Oxidative, Vascular, and Neurodegenerative Pathways.

Exploratory Analysis of Glaucoma-Associated SNPs in a Colombian Cohort Highlights Potential Involvement of Oxidative, Vascular, and Neurodegenerative Pathways.

Journal: Genes

Published: July 07, 2026

Central serous chorioretinopathy associated with topical prostaglandin analogues.

Central serous chorioretinopathy associated with topical prostaglandin analogues.

Journal: BMJ case reports

Published: June 30, 2026

Latanoprost Acid-Brimonidine, a New Amide Prodrug for Glaucoma Management Based on the Concept of Sustained Release.

Latanoprost Acid-Brimonidine, a New Amide Prodrug for Glaucoma Management Based on the Concept of Sustained Release.

Journal: Molecules (Basel, Switzerland)

Published: June 26, 2026

Punctal and Intracanalicular Drug Delivery Systems for Ophthalmic Use: A Narrative Review of Technologies, Clinical Outcomes, and Critical Quality Attributes.

Punctal and Intracanalicular Drug Delivery Systems for Ophthalmic Use: A Narrative Review of Technologies, Clinical Outcomes, and Critical Quality Attributes.

Journal: Pharmaceutics

Published: June 13, 2026

Emerging topical nonsteroidal therapies in pediatric dermatology: atopic dermatitis, psoriasis, alopecia areata, vitiligo, and seborrheic dermatitis.

Emerging topical nonsteroidal therapies in pediatric dermatology: atopic dermatitis, psoriasis, alopecia areata, vitiligo, and seborrheic dermatitis.

Journal: Current opinion in pediatrics

Published: June 04, 2026

Glaucoma prevalence and prescribing trends in New Zealand: A 10-year study.

Glaucoma prevalence and prescribing trends in New Zealand: A 10-year study.

Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)

Published: May 26, 2026

Daily topical latanoprost free acid exacerbates retinal ganglion cell degeneration in the DBA/2J mouse model of pigment dispersion glaucoma.

Daily topical latanoprost free acid exacerbates retinal ganglion cell degeneration in the DBA/2J mouse model of pigment dispersion glaucoma.

Journal: Prostaglandins & other lipid mediators

Published: April 20, 2026

Phakic Intraocular Lenses as a Potential Treatment for Pigment Dispersion Syndrome.

Phakic Intraocular Lenses as a Potential Treatment for Pigment Dispersion Syndrome.

Journal: Cureus

Published: April 12, 2026

Multimodal AI fuses proteomic and EHR data for rational prioritization of protein biomarkers in diabetic retinopathy.

Multimodal AI fuses proteomic and EHR data for rational prioritization of protein biomarkers in diabetic retinopathy.

Journal: medRxiv : the preprint server for health sciences

Published: April 01, 2026

Showing 1-12 of 2,372

Last Updated: 09/26/2026